News & Updates
Showing Multidisciplinary articles
Showing
Show Multimedia Only

HK-Chinese model predicts 10-year ASCVD risk in patients with schizophrenia-spectrum disorders
10 Apr 2026
byKanas Chan
A Hong Kong–Chinese (HK-Chinese) model achieves satisfactory accuracy in predicting 10-year atherosclerotic cardiovascular disease (ASCVD) risk in Chinese patients with schizophrenia-spectrum disorders, according to a population-based cohort study.
HK-Chinese model predicts 10-year ASCVD risk in patients with schizophrenia-spectrum disorders
10 Apr 2026
Finerenone protects kidneys in patients with T1D + CKD
09 Apr 2026
byChristina Lau
Finerenone significantly reduces albuminuria vs placebo and maintains a manageable safety profile in patients with type 1 diabetes (T1D) and chronic kidney disease (CKD) receiving background therapy with renin-angiotensin-aldosterone system inhibitors (RAASi), the phase III FINE-ONE trial has shown. These findings represent an important step forward since RAASi were introduced for renoprotection in T1D more than 30 years ago.







